Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...
Rhythm Pharmaceuticals (RYTM) initiated with a Buy/High Risk rating at Citi with a price target of $136 per share, reflecting strong conviction in the company’s growth potential. The next major growth ...
BMI and hyperphagia reductions have been observed in patients with PWS treated with setmelanotide at Month 3 (n=8) and Month 6 (n=5); 17 of 18 ...
The Alpha-Stim device helps reduce anxiety, depression, and insomnia symptoms through cranial electrotherapy stimulation. Alpha-Stim devices are considered safe with minimal side effects reported in a ...
If constantly being mogged by sigmas has you feeling like a fuhuhluhtoogan, and you have no idea what any of that means, you've come to the right place. This glossary aims to define and explain ...
BRISTOL, Tenn., Nov. 25, 2025 /PRNewswire/ -- Alpha Metallurgical Resources, Inc. (NYSE: AMR), a leading U.S. supplier of metallurgical products for the steel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results